CH507258A - Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone - Google Patents
Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazoloneInfo
- Publication number
- CH507258A CH507258A CH1009465A CH1009465A CH507258A CH 507258 A CH507258 A CH 507258A CH 1009465 A CH1009465 A CH 1009465A CH 1009465 A CH1009465 A CH 1009465A CH 507258 A CH507258 A CH 507258A
- Authority
- CH
- Switzerland
- Prior art keywords
- methyl
- phenyl
- acid
- sedatives
- formula
- Prior art date
Links
- 239000000932 sedative agent Substances 0.000 title abstract description 3
- 229940125723 sedative agent Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 239000002253 acid Substances 0.000 claims abstract description 5
- 125000003277 amino group Chemical group 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 6
- LGNHCOKGKIUFDW-UHFFFAOYSA-N 2-methyl-3-phenylquinazolin-4-one Chemical class CC1=NC2=CC=CC=C2C(=O)N1C1=CC=CC=C1 LGNHCOKGKIUFDW-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract description 4
- 239000007868 Raney catalyst Substances 0.000 abstract description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 abstract description 2
- 229910000564 Raney nickel Inorganic materials 0.000 abstract description 2
- 239000003054 catalyst Substances 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 229940125681 anticonvulsant agent Drugs 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- -1 2-methyl-3- (2-dimethylamino-phenyl) -6-amino--3H-4-quinazolone Chemical compound 0.000 description 6
- JEYCTXHKTXCGPB-UHFFFAOYSA-N Methaqualone Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC=CC=C2N=C1C JEYCTXHKTXCGPB-UHFFFAOYSA-N 0.000 description 4
- ZYHQGITXIJDDKC-UHFFFAOYSA-N 2-[2-(2-aminophenyl)ethyl]aniline Chemical group NC1=CC=CC=C1CCC1=CC=CC=C1N ZYHQGITXIJDDKC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960002803 methaqualone Drugs 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NQIAEQZFRRSSLU-UHFFFAOYSA-N 1-(2,1-benzoxazol-3-yl)-2-nitroethanone Chemical compound [N+](=O)([O-])CC(=O)C=1ON=C2C=CC=CC=12 NQIAEQZFRRSSLU-UHFFFAOYSA-N 0.000 description 1
- CBXXMZUUSMCOQV-UHFFFAOYSA-N 2-[acetyl(nitro)amino]benzoic acid Chemical compound [N+](=O)([O-])N(C=1C(C(=O)O)=CC=CC1)C(C)=O CBXXMZUUSMCOQV-UHFFFAOYSA-N 0.000 description 1
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical compound NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 1
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- GOZTWIXHTIBOHQ-UHFFFAOYSA-N 6-amino-2-methyl-3-(2-methylphenyl)quinazolin-4-one Chemical compound CC1=CC=CC=C1N1C(=O)C2=CC(N)=CC=C2N=C1C GOZTWIXHTIBOHQ-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- ZEGPOTDCGKCDON-UHFFFAOYSA-N CC(N(C1=CC=CC=C1)C(C1=C2[N+]([O-])=O)=O)=NC1=CC=C2[N+]([O-])=O Chemical class CC(N(C1=CC=CC=C1)C(C1=C2[N+]([O-])=O)=O)=NC1=CC=C2[N+]([O-])=O ZEGPOTDCGKCDON-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910019213 POCl3 Inorganic materials 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960004838 phosphoric acid Drugs 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 229940032330 sulfuric acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002569 water oil cream Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEB77866A DE1274129B (de) | 1964-07-28 | 1964-07-28 | 2-Methyl-3-(o-aminophenyl)-6-amino-3H-chinazolon-(4) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH507258A true CH507258A (de) | 1971-05-15 |
Family
ID=6979637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1009465A CH507258A (de) | 1964-07-28 | 1965-07-19 | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone |
Country Status (4)
| Country | Link |
|---|---|
| CH (1) | CH507258A (enrdf_load_stackoverflow) |
| DE (1) | DE1274129B (enrdf_load_stackoverflow) |
| FR (1) | FR4572M (enrdf_load_stackoverflow) |
| GB (1) | GB1054539A (enrdf_load_stackoverflow) |
-
0
- GB GB1054539D patent/GB1054539A/en active Active
-
1964
- 1964-07-28 DE DEB77866A patent/DE1274129B/de active Pending
-
1965
- 1965-07-19 CH CH1009465A patent/CH507258A/de not_active IP Right Cessation
- 1965-07-28 FR FR26397A patent/FR4572M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR4572M (enrdf_load_stackoverflow) | 1966-11-07 |
| DE1274129B (de) | 1968-08-01 |
| GB1054539A (enrdf_load_stackoverflow) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2402398C3 (de) | Aromatische Carbonsäureamid-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen | |
| DE1795587A1 (de) | Neue Nitrosoverbindungen und Verfahren zu ihrer Herstellung | |
| DE1770583A1 (de) | Thiazolderivate und ihre Herstellung | |
| DE2720545C3 (de) | Derivate des 2,4-Diamino-6,7-dimethoxychinazolins, ihre Herstellung und pharmazeutische Mittel | |
| CH507258A (de) | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone | |
| DE2166270C3 (de) | Nicotinoylaminoäthansulfonyl-2amino-thiazol | |
| DE2046577A1 (de) | Neue Pyrimidopyndazinderivate und Verfahren zu ihrer Herstellung | |
| AT257614B (de) | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone | |
| DE1912941B2 (de) | 1 -PhenyM-amino-e-methoxypridaziniumsalze | |
| DE1934392B2 (de) | Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung | |
| AT263015B (de) | Verfahren zur Herstellung neuer 2-Isopropyl- bzw. 2-Decyl-3-phenyl-3H-4-chinazolone sowie ihrer Säureadditionssalze | |
| DE1280875B (de) | 2-Isopropyl-3-(4-aminophenyl)-3H-chinazolon-(4) | |
| DE2427382A1 (de) | 3-benzylpyrido- eckige klammer auf 3,4-e eckige klammer zu -as-triazine und verfahren zu deren herstellung | |
| DE1229094B (de) | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-chinazolon-(4)-derivate | |
| AT258919B (de) | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone | |
| DE1960026A1 (de) | Neue Derivate des 3-Amino-1,2-benzisothiazols und ein Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel | |
| AT260941B (de) | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone sowie von deren Säureadditionssalzen | |
| AT258295B (de) | Verfahren zur Herstellung von neuen 2-Methyl-3-phenyl-3H-4-chinazolonen | |
| AT165069B (de) | Verfahren zur Herstellung neuer Phenoxyacetamidine | |
| DE2221281A1 (de) | Pyrazolderivate und Verfahren zu ihrer Herstellung | |
| AT201584B (de) | Verfahren zur Herstellung neuer Anilide und deren Salze | |
| AT329025B (de) | Verfahren zur herstellung von neuen halogenierten hydroxybenzylaminen sowie deren saureadditionssalzen | |
| AT260940B (de) | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone sowie von deren Säureadditionssalzen | |
| AT227707B (de) | Verfahren zur Herstellung von neuen Chinazolinonderivaten | |
| AT333292B (de) | Verfahren zur herstellung von neuen pyridaziniumverbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |